nodes	percent_of_prediction	percent_of_DWPC	metapath
Prilocaine—SCN3A—Interaction between L1 and Ankyrins—SPTBN4—kidney cancer	0.0183	0.0573	CbGpPWpGaD
Prilocaine—SCN3A—Interaction between L1 and Ankyrins—L1CAM—kidney cancer	0.0183	0.0573	CbGpPWpGaD
Prilocaine—SCN2A—Interaction between L1 and Ankyrins—SPTBN4—kidney cancer	0.0176	0.055	CbGpPWpGaD
Prilocaine—SCN2A—Interaction between L1 and Ankyrins—L1CAM—kidney cancer	0.0176	0.055	CbGpPWpGaD
Prilocaine—SCN1A—Interaction between L1 and Ankyrins—SPTBN4—kidney cancer	0.0169	0.053	CbGpPWpGaD
Prilocaine—SCN1A—Interaction between L1 and Ankyrins—L1CAM—kidney cancer	0.0169	0.053	CbGpPWpGaD
Prilocaine—SCN5A—Interaction between L1 and Ankyrins—SPTBN4—kidney cancer	0.0119	0.0373	CbGpPWpGaD
Prilocaine—SCN5A—Interaction between L1 and Ankyrins—L1CAM—kidney cancer	0.0119	0.0373	CbGpPWpGaD
Prilocaine—SCN3A—L1CAM interactions—SPTBN4—kidney cancer	0.00702	0.022	CbGpPWpGaD
Prilocaine—SCN3A—L1CAM interactions—L1CAM—kidney cancer	0.00702	0.022	CbGpPWpGaD
Prilocaine—SCN2A—L1CAM interactions—L1CAM—kidney cancer	0.00675	0.0211	CbGpPWpGaD
Prilocaine—SCN2A—L1CAM interactions—SPTBN4—kidney cancer	0.00675	0.0211	CbGpPWpGaD
Prilocaine—SCN1A—L1CAM interactions—SPTBN4—kidney cancer	0.00651	0.0204	CbGpPWpGaD
Prilocaine—SCN1A—L1CAM interactions—L1CAM—kidney cancer	0.00651	0.0204	CbGpPWpGaD
Prilocaine—SCN5A—L1CAM interactions—SPTBN4—kidney cancer	0.00457	0.0143	CbGpPWpGaD
Prilocaine—SCN5A—L1CAM interactions—L1CAM—kidney cancer	0.00457	0.0143	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—UNC5C—kidney cancer	0.0035	0.011	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—UNC5C—kidney cancer	0.00336	0.0105	CbGpPWpGaD
Prilocaine—SCN5A—Cardiac Progenitor Differentiation—PAX6—kidney cancer	0.00325	0.0102	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—UNC5C—kidney cancer	0.00324	0.0102	CbGpPWpGaD
Prilocaine—SCN3A—L1CAM interactions—PAK1—kidney cancer	0.00269	0.00842	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—SPTBN4—kidney cancer	0.00265	0.0083	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—L1CAM—kidney cancer	0.00265	0.0083	CbGpPWpGaD
Prilocaine—SCN2A—L1CAM interactions—PAK1—kidney cancer	0.00259	0.00809	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—SPTBN4—kidney cancer	0.00255	0.00798	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—L1CAM—kidney cancer	0.00255	0.00798	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—UNC5C—kidney cancer	0.0025	0.00782	CbGpPWpGaD
Prilocaine—SCN1A—L1CAM interactions—PAK1—kidney cancer	0.00249	0.0078	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—SPTBN4—kidney cancer	0.00246	0.00769	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—L1CAM—kidney cancer	0.00246	0.00769	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—UNC5C—kidney cancer	0.0024	0.00751	CbGpPWpGaD
Prilocaine—Nervous system disorder—Temsirolimus—kidney cancer	0.00236	0.00347	CcSEcCtD
Prilocaine—Swelling—Paclitaxel—kidney cancer	0.00232	0.00341	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—UNC5C—kidney cancer	0.00231	0.00724	CbGpPWpGaD
Prilocaine—SCN5A—Cardiac Progenitor Differentiation—IGF2—kidney cancer	0.0023	0.00721	CbGpPWpGaD
Prilocaine—Neuropathy peripheral—Sunitinib—kidney cancer	0.0023	0.00338	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—UNC5C—kidney cancer	0.00228	0.00714	CbGpPWpGaD
Prilocaine—Oedema—Pazopanib—kidney cancer	0.00227	0.00333	CcSEcCtD
Prilocaine—Depressed level of consciousness—Capecitabine—kidney cancer	0.00223	0.00328	CcSEcCtD
Prilocaine—Shock—Pazopanib—kidney cancer	0.00223	0.00328	CcSEcCtD
Prilocaine—Injury—Paclitaxel—kidney cancer	0.00222	0.00327	CcSEcCtD
Prilocaine—Nervous system disorder—Pazopanib—kidney cancer	0.00222	0.00327	CcSEcCtD
Prilocaine—Hyperhidrosis—Pazopanib—kidney cancer	0.00219	0.00322	CcSEcCtD
Prilocaine—Arrhythmia—Erlotinib—kidney cancer	0.00217	0.00319	CcSEcCtD
Prilocaine—Neuropathy—Capecitabine—kidney cancer	0.00217	0.00319	CcSEcCtD
Prilocaine—Paralysis—Doxorubicin—kidney cancer	0.00214	0.00315	CcSEcCtD
Prilocaine—Bradycardia—Sunitinib—kidney cancer	0.00214	0.00315	CcSEcCtD
Prilocaine—Somnolence—Temsirolimus—kidney cancer	0.00214	0.00315	CcSEcCtD
Prilocaine—Cardiac failure—Paclitaxel—kidney cancer	0.0021	0.00308	CcSEcCtD
Prilocaine—Hypoaesthesia—Sunitinib—kidney cancer	0.0021	0.00308	CcSEcCtD
Prilocaine—Bronchospasm—Gemcitabine—kidney cancer	0.00208	0.00305	CcSEcCtD
Prilocaine—Vision blurred—Everolimus—kidney cancer	0.00207	0.00304	CcSEcCtD
Prilocaine—Pain—Temsirolimus—kidney cancer	0.00206	0.00303	CcSEcCtD
Prilocaine—Tremor—Everolimus—kidney cancer	0.00206	0.00302	CcSEcCtD
Prilocaine—Tinnitus—Sorafenib—kidney cancer	0.00204	0.003	CcSEcCtD
Prilocaine—Paraesthesia—Pazopanib—kidney cancer	0.00204	0.00299	CcSEcCtD
Prilocaine—Anaemia—Vinblastine—kidney cancer	0.00204	0.00299	CcSEcCtD
Prilocaine—Anaemia—Everolimus—kidney cancer	0.00203	0.00298	CcSEcCtD
Prilocaine—Somnolence—Pazopanib—kidney cancer	0.00202	0.00296	CcSEcCtD
Prilocaine—Dermatitis atopic—Doxorubicin—kidney cancer	0.00201	0.00296	CcSEcCtD
Prilocaine—Syncope—Everolimus—kidney cancer	0.00197	0.00289	CcSEcCtD
Prilocaine—Arrhythmia—Sorafenib—kidney cancer	0.00195	0.00287	CcSEcCtD
Prilocaine—Neuropathy peripheral—Vincristine—kidney cancer	0.00194	0.00286	CcSEcCtD
Prilocaine—Cardiac arrest—Paclitaxel—kidney cancer	0.00194	0.00286	CcSEcCtD
Prilocaine—Pain—Pazopanib—kidney cancer	0.00194	0.00285	CcSEcCtD
Prilocaine—Loss of consciousness—Everolimus—kidney cancer	0.00193	0.00283	CcSEcCtD
Prilocaine—Swelling—Capecitabine—kidney cancer	0.0019	0.0028	CcSEcCtD
Prilocaine—Hypertension—Vinblastine—kidney cancer	0.0019	0.0028	CcSEcCtD
Prilocaine—Sweating—Vincristine—kidney cancer	0.0019	0.0028	CcSEcCtD
Prilocaine—Syncope—Erlotinib—kidney cancer	0.0019	0.00279	CcSEcCtD
Prilocaine—Feeling hot—Doxorubicin—kidney cancer	0.0019	0.00279	CcSEcCtD
Prilocaine—Hypertension—Everolimus—kidney cancer	0.00189	0.00278	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—SPTBN4—kidney cancer	0.00189	0.00593	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—L1CAM—kidney cancer	0.00189	0.00593	CbGpPWpGaD
Prilocaine—Arrhythmia—Sunitinib—kidney cancer	0.00188	0.00276	CcSEcCtD
Prilocaine—Anxiety—Everolimus—kidney cancer	0.00186	0.00274	CcSEcCtD
Prilocaine—Loss of consciousness—Erlotinib—kidney cancer	0.00186	0.00274	CcSEcCtD
Prilocaine—Neuropathy peripheral—Gemcitabine—kidney cancer	0.00184	0.00271	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—SPTBN4—kidney cancer	0.00182	0.00569	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—L1CAM—kidney cancer	0.00182	0.00569	CbGpPWpGaD
Prilocaine—Sweating—Gemcitabine—kidney cancer	0.0018	0.00265	CcSEcCtD
Prilocaine—Anxiety—Erlotinib—kidney cancer	0.0018	0.00264	CcSEcCtD
Prilocaine—Oedema—Everolimus—kidney cancer	0.00179	0.00263	CcSEcCtD
Prilocaine—Hypersensitivity—Temsirolimus—kidney cancer	0.00177	0.00261	CcSEcCtD
Prilocaine—Hypoaesthesia—Vincristine—kidney cancer	0.00177	0.0026	CcSEcCtD
Prilocaine—Shock—Everolimus—kidney cancer	0.00176	0.00259	CcSEcCtD
Prilocaine—Anaemia—Sorafenib—kidney cancer	0.00176	0.00259	CcSEcCtD
Prilocaine—Nervous system disorder—Everolimus—kidney cancer	0.00176	0.00258	CcSEcCtD
Prilocaine—SCN5A—Cardiac Progenitor Differentiation—KDR—kidney cancer	0.00175	0.00549	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—L1CAM—kidney cancer	0.00175	0.00549	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—SPTBN4—kidney cancer	0.00175	0.00549	CbGpPWpGaD
Prilocaine—SCN5A—L1CAM interactions—PAK1—kidney cancer	0.00175	0.00548	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—HSPD1—kidney cancer	0.00175	0.00547	CbGpPWpGaD
Prilocaine—Hyperhidrosis—Everolimus—kidney cancer	0.00173	0.00254	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—SPTBN4—kidney cancer	0.00173	0.00541	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—L1CAM—kidney cancer	0.00173	0.00541	CbGpPWpGaD
Prilocaine—Oedema—Erlotinib—kidney cancer	0.00173	0.00254	CcSEcCtD
Prilocaine—Asthenia—Temsirolimus—kidney cancer	0.00173	0.00254	CcSEcCtD
Prilocaine—Cardiac failure—Capecitabine—kidney cancer	0.00172	0.00253	CcSEcCtD
Prilocaine—Syncope—Sorafenib—kidney cancer	0.00171	0.00251	CcSEcCtD
Prilocaine—Extravasation—Doxorubicin—kidney cancer	0.00171	0.00251	CcSEcCtD
Prilocaine—Shock—Erlotinib—kidney cancer	0.0017	0.0025	CcSEcCtD
Prilocaine—Nervous system disorder—Erlotinib—kidney cancer	0.00169	0.00249	CcSEcCtD
Prilocaine—Anaemia—Sunitinib—kidney cancer	0.00169	0.00249	CcSEcCtD
Prilocaine—Diplopia—Capecitabine—kidney cancer	0.00168	0.00247	CcSEcCtD
Prilocaine—Osteoarthritis—Capecitabine—kidney cancer	0.00168	0.00247	CcSEcCtD
Prilocaine—Loss of consciousness—Sorafenib—kidney cancer	0.00167	0.00246	CcSEcCtD
Prilocaine—Hypotension—Everolimus—kidney cancer	0.00167	0.00246	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—CER1—kidney cancer	0.00166	0.00518	CbGpPWpGaD
Prilocaine—Hypertension—Sorafenib—kidney cancer	0.00164	0.00242	CcSEcCtD
Prilocaine—Asthenia—Pazopanib—kidney cancer	0.00163	0.00239	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—UNC5C—kidney cancer	0.00163	0.00509	CbGpPWpGaD
Prilocaine—SCN5A—Cardiac Progenitor Differentiation—KIT—kidney cancer	0.00162	0.00506	CbGpPWpGaD
Prilocaine—Paraesthesia—Vinblastine—kidney cancer	0.00161	0.00237	CcSEcCtD
Prilocaine—Paraesthesia—Everolimus—kidney cancer	0.00161	0.00236	CcSEcCtD
Prilocaine—Anaemia—Dactinomycin—kidney cancer	0.0016	0.00236	CcSEcCtD
Prilocaine—Cardiac arrest—Capecitabine—kidney cancer	0.0016	0.00235	CcSEcCtD
Prilocaine—Somnolence—Everolimus—kidney cancer	0.00159	0.00234	CcSEcCtD
Prilocaine—Dizziness—Temsirolimus—kidney cancer	0.00159	0.00234	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—CER1—kidney cancer	0.00159	0.00498	CbGpPWpGaD
Prilocaine—Hypertension—Sunitinib—kidney cancer	0.00158	0.00233	CcSEcCtD
Prilocaine—Dysarthria—Doxorubicin—kidney cancer	0.00158	0.00232	CcSEcCtD
Prilocaine—Anaphylactic shock—Sorafenib—kidney cancer	0.00155	0.00228	CcSEcCtD
Prilocaine—Neuropathy peripheral—Paclitaxel—kidney cancer	0.00154	0.00227	CcSEcCtD
Prilocaine—Pain—Vinblastine—kidney cancer	0.00154	0.00226	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—CER1—kidney cancer	0.00153	0.0048	CbGpPWpGaD
Prilocaine—Pain—Everolimus—kidney cancer	0.00153	0.00225	CcSEcCtD
Prilocaine—Vomiting—Temsirolimus—kidney cancer	0.00153	0.00225	CcSEcCtD
Prilocaine—Shock—Sorafenib—kidney cancer	0.00153	0.00225	CcSEcCtD
Prilocaine—Nervous system disorder—Sorafenib—kidney cancer	0.00152	0.00224	CcSEcCtD
Prilocaine—Arrhythmia—Gemcitabine—kidney cancer	0.00151	0.00222	CcSEcCtD
Prilocaine—Dizziness—Pazopanib—kidney cancer	0.0015	0.0022	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—EPAS1—kidney cancer	0.0015	0.00468	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—HNF1A—kidney cancer	0.0015	0.00468	CbGpPWpGaD
Prilocaine—Oedema—Sunitinib—kidney cancer	0.0015	0.0022	CcSEcCtD
Prilocaine—Feeling abnormal—Vinblastine—kidney cancer	0.00148	0.00218	CcSEcCtD
Prilocaine—Pain—Erlotinib—kidney cancer	0.00148	0.00217	CcSEcCtD
Prilocaine—Feeling abnormal—Everolimus—kidney cancer	0.00148	0.00217	CcSEcCtD
Prilocaine—Shock—Sunitinib—kidney cancer	0.00147	0.00216	CcSEcCtD
Prilocaine—Nervous system disorder—Sunitinib—kidney cancer	0.00147	0.00216	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—IL13—kidney cancer	0.00147	0.00459	CbGpPWpGaD
Prilocaine—Vomiting—Pazopanib—kidney cancer	0.00144	0.00212	CcSEcCtD
Prilocaine—Bradycardia—Paclitaxel—kidney cancer	0.00144	0.00212	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—EPAS1—kidney cancer	0.00144	0.0045	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—HNF1A—kidney cancer	0.00144	0.0045	CbGpPWpGaD
Prilocaine—Anaemia—Vincristine—kidney cancer	0.00143	0.00211	CcSEcCtD
Prilocaine—Nausea—Temsirolimus—kidney cancer	0.00143	0.0021	CcSEcCtD
Prilocaine—Bronchospasm—Capecitabine—kidney cancer	0.00143	0.0021	CcSEcCtD
Prilocaine—Oedema—Dactinomycin—kidney cancer	0.00142	0.00208	CcSEcCtD
Prilocaine—Hypoaesthesia—Paclitaxel—kidney cancer	0.00141	0.00207	CcSEcCtD
Prilocaine—Neuropathy—Doxorubicin—kidney cancer	0.0014	0.00206	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—HNF1A—kidney cancer	0.00139	0.00434	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—EPAS1—kidney cancer	0.00139	0.00434	CbGpPWpGaD
Prilocaine—Anaemia—Gemcitabine—kidney cancer	0.00136	0.002	CcSEcCtD
Prilocaine—Nausea—Pazopanib—kidney cancer	0.00135	0.00198	CcSEcCtD
Prilocaine—Paraesthesia—Sunitinib—kidney cancer	0.00134	0.00197	CcSEcCtD
Prilocaine—Hypertension—Vincristine—kidney cancer	0.00134	0.00197	CcSEcCtD
Prilocaine—Pain—Sorafenib—kidney cancer	0.00133	0.00195	CcSEcCtD
Prilocaine—Hypersensitivity—Vinblastine—kidney cancer	0.00132	0.00195	CcSEcCtD
Prilocaine—Hypersensitivity—Everolimus—kidney cancer	0.00132	0.00194	CcSEcCtD
Prilocaine—Tinnitus—Paclitaxel—kidney cancer	0.00132	0.00194	CcSEcCtD
Prilocaine—Asthenia—Vinblastine—kidney cancer	0.00129	0.0019	CcSEcCtD
Prilocaine—Asthenia—Everolimus—kidney cancer	0.00129	0.00189	CcSEcCtD
Prilocaine—Pain—Sunitinib—kidney cancer	0.00128	0.00188	CcSEcCtD
Prilocaine—Hypertension—Gemcitabine—kidney cancer	0.00127	0.00187	CcSEcCtD
Prilocaine—Neuropathy peripheral—Capecitabine—kidney cancer	0.00127	0.00186	CcSEcCtD
Prilocaine—Oedema—Vincristine—kidney cancer	0.00127	0.00186	CcSEcCtD
Prilocaine—Anaphylactic shock—Vincristine—kidney cancer	0.00127	0.00186	CcSEcCtD
Prilocaine—Arrhythmia—Paclitaxel—kidney cancer	0.00126	0.00186	CcSEcCtD
Prilocaine—Nervous system disorder—Vincristine—kidney cancer	0.00124	0.00182	CcSEcCtD
Prilocaine—Asthenia—Erlotinib—kidney cancer	0.00124	0.00182	CcSEcCtD
Prilocaine—Urticaria—Sorafenib—kidney cancer	0.00124	0.00182	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—L1CAM—kidney cancer	0.00123	0.00386	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—SPTBN4—kidney cancer	0.00123	0.00386	CbGpPWpGaD
Prilocaine—Hyperhidrosis—Vincristine—kidney cancer	0.00122	0.0018	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—HNF1B—kidney cancer	0.00122	0.00382	CbGpPWpGaD
Prilocaine—Pain—Dactinomycin—kidney cancer	0.00121	0.00178	CcSEcCtD
Prilocaine—Tension—Paclitaxel—kidney cancer	0.00121	0.00178	CcSEcCtD
Prilocaine—Oedema—Gemcitabine—kidney cancer	0.0012	0.00176	CcSEcCtD
Prilocaine—Anaphylactic shock—Gemcitabine—kidney cancer	0.0012	0.00176	CcSEcCtD
Prilocaine—Nervousness—Paclitaxel—kidney cancer	0.0012	0.00176	CcSEcCtD
Prilocaine—Dizziness—Vinblastine—kidney cancer	0.00119	0.00175	CcSEcCtD
Prilocaine—Dizziness—Everolimus—kidney cancer	0.00118	0.00174	CcSEcCtD
Prilocaine—Hypotension—Vincristine—kidney cancer	0.00118	0.00174	CcSEcCtD
Prilocaine—Bradycardia—Capecitabine—kidney cancer	0.00118	0.00174	CcSEcCtD
Prilocaine—Nervous system disorder—Gemcitabine—kidney cancer	0.00118	0.00173	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—HNF1B—kidney cancer	0.00117	0.00367	CbGpPWpGaD
Prilocaine—Feeling abnormal—Dactinomycin—kidney cancer	0.00117	0.00172	CcSEcCtD
Prilocaine—Vision blurred—Paclitaxel—kidney cancer	0.00116	0.00171	CcSEcCtD
Prilocaine—Hyperhidrosis—Gemcitabine—kidney cancer	0.00116	0.00171	CcSEcCtD
Prilocaine—Hypoaesthesia—Capecitabine—kidney cancer	0.00116	0.0017	CcSEcCtD
Prilocaine—Tremor—Paclitaxel—kidney cancer	0.00115	0.0017	CcSEcCtD
Prilocaine—Hypersensitivity—Sorafenib—kidney cancer	0.00115	0.00168	CcSEcCtD
Prilocaine—Vomiting—Vinblastine—kidney cancer	0.00114	0.00168	CcSEcCtD
Prilocaine—Dizziness—Erlotinib—kidney cancer	0.00114	0.00168	CcSEcCtD
Prilocaine—Vomiting—Everolimus—kidney cancer	0.00114	0.00167	CcSEcCtD
Prilocaine—Anaemia—Paclitaxel—kidney cancer	0.00114	0.00167	CcSEcCtD
Prilocaine—Paraesthesia—Vincristine—kidney cancer	0.00114	0.00167	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—HNF1B—kidney cancer	0.00113	0.00354	CbGpPWpGaD
Prilocaine—Hypotension—Gemcitabine—kidney cancer	0.00112	0.00165	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.00112	0.00164	CcSEcCtD
Prilocaine—Asthenia—Sorafenib—kidney cancer	0.00112	0.00164	CcSEcCtD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.00111	0.00348	CbGpPWpGaD
Prilocaine—Cardiac failure—Doxorubicin—kidney cancer	0.00111	0.00163	CcSEcCtD
Prilocaine—Syncope—Paclitaxel—kidney cancer	0.0011	0.00162	CcSEcCtD
Prilocaine—Hypersensitivity—Sunitinib—kidney cancer	0.0011	0.00162	CcSEcCtD
Prilocaine—Vomiting—Erlotinib—kidney cancer	0.0011	0.00161	CcSEcCtD
Prilocaine—Tinnitus—Capecitabine—kidney cancer	0.00108	0.00159	CcSEcCtD
Prilocaine—Loss of consciousness—Paclitaxel—kidney cancer	0.00108	0.00159	CcSEcCtD
Prilocaine—Pain—Vincristine—kidney cancer	0.00108	0.00159	CcSEcCtD
Prilocaine—Osteoarthritis—Doxorubicin—kidney cancer	0.00108	0.00159	CcSEcCtD
Prilocaine—Diplopia—Doxorubicin—kidney cancer	0.00108	0.00159	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—CER1—kidney cancer	0.00108	0.00337	CbGpPWpGaD
Prilocaine—Paraesthesia—Gemcitabine—kidney cancer	0.00108	0.00158	CcSEcCtD
Prilocaine—Asthenia—Sunitinib—kidney cancer	0.00107	0.00158	CcSEcCtD
Prilocaine—Nausea—Vinblastine—kidney cancer	0.00107	0.00157	CcSEcCtD
Prilocaine—Somnolence—Gemcitabine—kidney cancer	0.00107	0.00157	CcSEcCtD
Prilocaine—Nausea—Everolimus—kidney cancer	0.00106	0.00156	CcSEcCtD
Prilocaine—Hypertension—Paclitaxel—kidney cancer	0.00106	0.00156	CcSEcCtD
Prilocaine—Anxiety—Paclitaxel—kidney cancer	0.00104	0.00154	CcSEcCtD
Prilocaine—Hypersensitivity—Dactinomycin—kidney cancer	0.00104	0.00153	CcSEcCtD
Prilocaine—Arrhythmia—Capecitabine—kidney cancer	0.00104	0.00152	CcSEcCtD
Prilocaine—Cardiac arrest—Doxorubicin—kidney cancer	0.00103	0.00151	CcSEcCtD
Prilocaine—Dizziness—Sorafenib—kidney cancer	0.00103	0.00151	CcSEcCtD
Prilocaine—Pain—Gemcitabine—kidney cancer	0.00103	0.00151	CcSEcCtD
Prilocaine—Nausea—Erlotinib—kidney cancer	0.00103	0.00151	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—PAK1—kidney cancer	0.00102	0.00318	CbGpPWpGaD
Prilocaine—Asthenia—Dactinomycin—kidney cancer	0.00102	0.00149	CcSEcCtD
Prilocaine—Confusional state—Paclitaxel—kidney cancer	0.00101	0.00149	CcSEcCtD
Prilocaine—Anaphylactic shock—Paclitaxel—kidney cancer	0.00101	0.00148	CcSEcCtD
Prilocaine—Oedema—Paclitaxel—kidney cancer	0.00101	0.00148	CcSEcCtD
Prilocaine—Dizziness—Sunitinib—kidney cancer	0.000989	0.00145	CcSEcCtD
Prilocaine—Feeling abnormal—Gemcitabine—kidney cancer	0.000989	0.00145	CcSEcCtD
Prilocaine—Shock—Paclitaxel—kidney cancer	0.000989	0.00145	CcSEcCtD
Prilocaine—Vomiting—Sorafenib—kidney cancer	0.000989	0.00145	CcSEcCtD
Prilocaine—Nervous system disorder—Paclitaxel—kidney cancer	0.000986	0.00145	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—PAK1—kidney cancer	0.000977	0.00306	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—EPAS1—kidney cancer	0.000975	0.00305	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—HNF1A—kidney cancer	0.000975	0.00305	CbGpPWpGaD
Prilocaine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000972	0.00143	CcSEcCtD
Prilocaine—Vision blurred—Capecitabine—kidney cancer	0.000952	0.0014	CcSEcCtD
Prilocaine—Vomiting—Sunitinib—kidney cancer	0.000951	0.0014	CcSEcCtD
Prilocaine—Tremor—Capecitabine—kidney cancer	0.000947	0.00139	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—PAK1—kidney cancer	0.000942	0.00295	CbGpPWpGaD
Prilocaine—Hypotension—Paclitaxel—kidney cancer	0.000939	0.00138	CcSEcCtD
Prilocaine—Anaemia—Capecitabine—kidney cancer	0.000934	0.00137	CcSEcCtD
Prilocaine—Hypersensitivity—Vincristine—kidney cancer	0.000932	0.00137	CcSEcCtD
Prilocaine—Nausea—Sorafenib—kidney cancer	0.000923	0.00136	CcSEcCtD
Prilocaine—Asthenia—Vincristine—kidney cancer	0.000908	0.00133	CcSEcCtD
Prilocaine—Syncope—Capecitabine—kidney cancer	0.000906	0.00133	CcSEcCtD
Prilocaine—Paraesthesia—Paclitaxel—kidney cancer	0.000902	0.00133	CcSEcCtD
Prilocaine—Vomiting—Dactinomycin—kidney cancer	0.0009	0.00132	CcSEcCtD
Prilocaine—Somnolence—Paclitaxel—kidney cancer	0.000893	0.00131	CcSEcCtD
Prilocaine—Nausea—Sunitinib—kidney cancer	0.000889	0.00131	CcSEcCtD
Prilocaine—Loss of consciousness—Capecitabine—kidney cancer	0.000888	0.00131	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—CTNNA1—kidney cancer	0.000874	0.00274	CbGpPWpGaD
Prilocaine—SCN3A—L1CAM interactions—MAPK3—kidney cancer	0.000873	0.00273	CbGpPWpGaD
Prilocaine—Hypertension—Capecitabine—kidney cancer	0.000872	0.00128	CcSEcCtD
Prilocaine—Asthenia—Gemcitabine—kidney cancer	0.000861	0.00127	CcSEcCtD
Prilocaine—Pain—Paclitaxel—kidney cancer	0.000859	0.00126	CcSEcCtD
Prilocaine—Anxiety—Capecitabine—kidney cancer	0.000857	0.00126	CcSEcCtD
Prilocaine—Nausea—Dactinomycin—kidney cancer	0.000841	0.00124	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—CTNNA1—kidney cancer	0.00084	0.00263	CbGpPWpGaD
Prilocaine—SCN2A—L1CAM interactions—MAPK3—kidney cancer	0.000839	0.00262	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—PAX6—kidney cancer	0.000837	0.00262	CbGpPWpGaD
Prilocaine—Dizziness—Vincristine—kidney cancer	0.000837	0.00123	CcSEcCtD
Prilocaine—Drowsiness—Doxorubicin—kidney cancer	0.000834	0.00123	CcSEcCtD
Prilocaine—Confusional state—Capecitabine—kidney cancer	0.000832	0.00122	CcSEcCtD
Prilocaine—SCN3A—L1CAM interactions—MAPK1—kidney cancer	0.00083	0.0026	CbGpPWpGaD
Prilocaine—Feeling abnormal—Paclitaxel—kidney cancer	0.000828	0.00122	CcSEcCtD
Prilocaine—Oedema—Capecitabine—kidney cancer	0.000825	0.00121	CcSEcCtD
Prilocaine—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000817	0.0012	CcSEcCtD
Prilocaine—Shock—Capecitabine—kidney cancer	0.000811	0.00119	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—CTNNA1—kidney cancer	0.00081	0.00254	CbGpPWpGaD
Prilocaine—Nervous system disorder—Capecitabine—kidney cancer	0.000809	0.00119	CcSEcCtD
Prilocaine—SCN1A—L1CAM interactions—MAPK3—kidney cancer	0.000809	0.00253	CbGpPWpGaD
Prilocaine—Vomiting—Vincristine—kidney cancer	0.000805	0.00118	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—PAX6—kidney cancer	0.000804	0.00252	CbGpPWpGaD
Prilocaine—Sweating—Doxorubicin—kidney cancer	0.000799	0.00117	CcSEcCtD
Prilocaine—Urticaria—Paclitaxel—kidney cancer	0.000798	0.00117	CcSEcCtD
Prilocaine—SCN2A—L1CAM interactions—MAPK1—kidney cancer	0.000798	0.0025	CbGpPWpGaD
Prilocaine—Hyperhidrosis—Capecitabine—kidney cancer	0.000797	0.00117	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—HNF1B—kidney cancer	0.000795	0.00249	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—PAX6—kidney cancer	0.000775	0.00243	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.000773	0.00242	CbGpPWpGaD
Prilocaine—Hypotension—Capecitabine—kidney cancer	0.000771	0.00113	CcSEcCtD
Prilocaine—SCN1A—L1CAM interactions—MAPK1—kidney cancer	0.000769	0.00241	CbGpPWpGaD
Prilocaine—Vomiting—Gemcitabine—kidney cancer	0.000763	0.00112	CcSEcCtD
Prilocaine—Bradycardia—Doxorubicin—kidney cancer	0.000762	0.00112	CcSEcCtD
Prilocaine—Nausea—Vincristine—kidney cancer	0.000752	0.0011	CcSEcCtD
Prilocaine—Hypoaesthesia—Doxorubicin—kidney cancer	0.000745	0.00109	CcSEcCtD
Prilocaine—Paraesthesia—Capecitabine—kidney cancer	0.000741	0.00109	CcSEcCtD
Prilocaine—Hypersensitivity—Paclitaxel—kidney cancer	0.00074	0.00109	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—PAK1—kidney cancer	0.000726	0.00227	CbGpPWpGaD
Prilocaine—Asthenia—Paclitaxel—kidney cancer	0.000721	0.00106	CcSEcCtD
Prilocaine—Nausea—Gemcitabine—kidney cancer	0.000713	0.00105	CcSEcCtD
Prilocaine—Pain—Capecitabine—kidney cancer	0.000705	0.00104	CcSEcCtD
Prilocaine—Tinnitus—Doxorubicin—kidney cancer	0.000698	0.00103	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—PAK1—kidney cancer	0.000697	0.00218	CbGpPWpGaD
Prilocaine—Feeling abnormal—Capecitabine—kidney cancer	0.00068	0.000999	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—PAK1—kidney cancer	0.000672	0.0021	CbGpPWpGaD
Prilocaine—Arrhythmia—Doxorubicin—kidney cancer	0.000668	0.000982	CcSEcCtD
Prilocaine—Dizziness—Paclitaxel—kidney cancer	0.000665	0.000977	CcSEcCtD
Prilocaine—SCN5A—Axon guidance—PAK1—kidney cancer	0.000662	0.00207	CbGpPWpGaD
Prilocaine—Urticaria—Capecitabine—kidney cancer	0.000655	0.000963	CcSEcCtD
Prilocaine—Tension—Doxorubicin—kidney cancer	0.000639	0.000939	CcSEcCtD
Prilocaine—Vomiting—Paclitaxel—kidney cancer	0.000639	0.000939	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—KDR—kidney cancer	0.000633	0.00198	CbGpPWpGaD
Prilocaine—Nervousness—Doxorubicin—kidney cancer	0.000633	0.00093	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—MET—kidney cancer	0.000619	0.00194	CbGpPWpGaD
Prilocaine—Vision blurred—Doxorubicin—kidney cancer	0.000614	0.000902	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—KDR—kidney cancer	0.000608	0.0019	CbGpPWpGaD
Prilocaine—Hypersensitivity—Capecitabine—kidney cancer	0.000608	0.000893	CcSEcCtD
Prilocaine—Anaemia—Doxorubicin—kidney cancer	0.000602	0.000885	CcSEcCtD
Prilocaine—Nausea—Paclitaxel—kidney cancer	0.000597	0.000877	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—MET—kidney cancer	0.000595	0.00186	CbGpPWpGaD
Prilocaine—Asthenia—Capecitabine—kidney cancer	0.000592	0.00087	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—KDR—kidney cancer	0.000586	0.00183	CbGpPWpGaD
Prilocaine—Syncope—Doxorubicin—kidney cancer	0.000584	0.000859	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—MET—kidney cancer	0.000574	0.0018	CbGpPWpGaD
Prilocaine—Loss of consciousness—Doxorubicin—kidney cancer	0.000573	0.000841	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—CTNNA1—kidney cancer	0.00057	0.00178	CbGpPWpGaD
Prilocaine—SCN5A—L1CAM interactions—MAPK3—kidney cancer	0.000568	0.00178	CbGpPWpGaD
Prilocaine—Hypertension—Doxorubicin—kidney cancer	0.000562	0.000827	CcSEcCtD
Prilocaine—Anxiety—Doxorubicin—kidney cancer	0.000553	0.000812	CcSEcCtD
Prilocaine—Dizziness—Capecitabine—kidney cancer	0.000545	0.000802	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—PAX6—kidney cancer	0.000545	0.00171	CbGpPWpGaD
Prilocaine—SCN5A—L1CAM interactions—MAPK1—kidney cancer	0.000541	0.00169	CbGpPWpGaD
Prilocaine—Confusional state—Doxorubicin—kidney cancer	0.000536	0.000788	CcSEcCtD
Prilocaine—Oedema—Doxorubicin—kidney cancer	0.000532	0.000781	CcSEcCtD
Prilocaine—Anaphylactic shock—Doxorubicin—kidney cancer	0.000532	0.000781	CcSEcCtD
Prilocaine—Vomiting—Capecitabine—kidney cancer	0.000524	0.000771	CcSEcCtD
Prilocaine—Shock—Doxorubicin—kidney cancer	0.000523	0.000769	CcSEcCtD
Prilocaine—Nervous system disorder—Doxorubicin—kidney cancer	0.000521	0.000766	CcSEcCtD
Prilocaine—Hyperhidrosis—Doxorubicin—kidney cancer	0.000514	0.000755	CcSEcCtD
Prilocaine—Hypotension—Doxorubicin—kidney cancer	0.000497	0.00073	CcSEcCtD
Prilocaine—Nausea—Capecitabine—kidney cancer	0.00049	0.00072	CcSEcCtD
Prilocaine—Paraesthesia—Doxorubicin—kidney cancer	0.000477	0.000702	CcSEcCtD
Prilocaine—Somnolence—Doxorubicin—kidney cancer	0.000473	0.000695	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—PAK1—kidney cancer	0.000473	0.00148	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000466	0.00146	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000463	0.00145	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—RAF1—kidney cancer	0.000458	0.00143	CbGpPWpGaD
Prilocaine—Pain—Doxorubicin—kidney cancer	0.000455	0.000668	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—ERBB2—kidney cancer	0.000453	0.00142	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—KDR—kidney cancer	0.000452	0.00141	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MET—kidney cancer	0.000442	0.00138	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—RAF1—kidney cancer	0.00044	0.00138	CbGpPWpGaD
Prilocaine—Feeling abnormal—Doxorubicin—kidney cancer	0.000438	0.000644	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—ERBB2—kidney cancer	0.000435	0.00136	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—KDR—kidney cancer	0.000434	0.00136	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MET—kidney cancer	0.000425	0.00133	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—RAF1—kidney cancer	0.000424	0.00133	CbGpPWpGaD
Prilocaine—Urticaria—Doxorubicin—kidney cancer	0.000422	0.000621	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—ERBB2—kidney cancer	0.000419	0.00131	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—KDR—kidney cancer	0.000418	0.00131	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—KDR—kidney cancer	0.000412	0.00129	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MET—kidney cancer	0.000409	0.00128	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000407	0.00128	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MET—kidney cancer	0.000403	0.00126	CbGpPWpGaD
Prilocaine—Hypersensitivity—Doxorubicin—kidney cancer	0.000392	0.000576	CcSEcCtD
Prilocaine—Asthenia—Doxorubicin—kidney cancer	0.000381	0.000561	CcSEcCtD
Prilocaine—Dizziness—Doxorubicin—kidney cancer	0.000352	0.000517	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—VEGFA—kidney cancer	0.000349	0.00109	CbGpPWpGaD
Prilocaine—Vomiting—Doxorubicin—kidney cancer	0.000338	0.000497	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—VEGFA—kidney cancer	0.000335	0.00105	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—MAPK3—kidney cancer	0.00033	0.00103	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—RAF1—kidney cancer	0.000326	0.00102	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—RELA—kidney cancer	0.000325	0.00102	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—ERBB2—kidney cancer	0.000323	0.00101	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—VEGFA—kidney cancer	0.000323	0.00101	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—MAPK3—kidney cancer	0.000317	0.000992	CbGpPWpGaD
Prilocaine—Nausea—Doxorubicin—kidney cancer	0.000316	0.000464	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—MAPK1—kidney cancer	0.000314	0.000982	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—RAF1—kidney cancer	0.000314	0.000982	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—RELA—kidney cancer	0.000312	0.000977	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—ERBB2—kidney cancer	0.00031	0.000971	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—MAPK3—kidney cancer	0.000306	0.000956	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—RAF1—kidney cancer	0.000302	0.000947	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—MAPK1—kidney cancer	0.000302	0.000943	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—RELA—kidney cancer	0.000301	0.000942	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—ERBB2—kidney cancer	0.000299	0.000936	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—RAF1—kidney cancer	0.000298	0.000933	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—KRAS—kidney cancer	0.000296	0.000928	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—ERBB2—kidney cancer	0.000295	0.000923	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—KDR—kidney cancer	0.000294	0.00092	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—MAPK1—kidney cancer	0.000291	0.00091	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MET—kidney cancer	0.000288	0.000901	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—KRAS—kidney cancer	0.000285	0.000891	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—CTNNB1—kidney cancer	0.000283	0.000884	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—KRAS—kidney cancer	0.000275	0.000859	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—CTNNB1—kidney cancer	0.000272	0.00085	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—CTNNB1—kidney cancer	0.000262	0.000819	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—VEGFA—kidney cancer	0.000249	0.000779	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—VEGFA—kidney cancer	0.000239	0.000748	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MAPK3—kidney cancer	0.000235	0.000736	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—VEGFA—kidney cancer	0.00023	0.000721	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—VEGFA—kidney cancer	0.000227	0.000711	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MAPK3—kidney cancer	0.000226	0.000708	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MAPK1—kidney cancer	0.000224	0.000701	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MAPK3—kidney cancer	0.000218	0.000682	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MAPK1—kidney cancer	0.000215	0.000673	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MAPK3—kidney cancer	0.000215	0.000672	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—RAF1—kidney cancer	0.000213	0.000665	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—RELA—kidney cancer	0.000212	0.000663	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—KRAS—kidney cancer	0.000212	0.000662	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—ERBB2—kidney cancer	0.00021	0.000658	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MAPK1—kidney cancer	0.000207	0.000649	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MAPK1—kidney cancer	0.000204	0.00064	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—KRAS—kidney cancer	0.000203	0.000636	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—KRAS—kidney cancer	0.000196	0.000613	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—KRAS—kidney cancer	0.000193	0.000604	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—CTNNB1—kidney cancer	0.000184	0.000576	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—VEGFA—kidney cancer	0.000162	0.000507	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MAPK3—kidney cancer	0.000153	0.00048	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MAPK1—kidney cancer	0.000146	0.000456	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—KRAS—kidney cancer	0.000138	0.000431	CbGpPWpGaD
